NCT02743312

Brief Summary

The goal of this pilot study is to test the protocol for investigating the longer-term effects of torso weighting on physical activity, number of falls, and muscle activation (when muscles turn on and off and how intensely) in five volunteers with multiple sclerosis. The hypotheses of this study include: torso weighting will (1) increase physical activity, (2) decrease the number of falls, and (3) improve the timing and coordination of muscle activation during balance perturbations.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for not_applicable multiple-sclerosis

Timeline
Completed

Started Nov 2015

Shorter than P25 for not_applicable multiple-sclerosis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 7, 2015

Completed
25 days until next milestone

Study Start

First participant enrolled

November 1, 2015

Completed
6 months until next milestone

First Posted

Study publicly available on registry

April 19, 2016

Completed
12 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2016

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
2.4 years until next milestone

Results Posted

Study results publicly available

November 6, 2018

Completed
Last Updated

November 6, 2018

Status Verified

October 1, 2018

Enrollment Period

6 months

First QC Date

October 7, 2015

Results QC Date

April 16, 2018

Last Update Submit

October 9, 2018

Conditions

Keywords

Balance-Based Torso-WeightingPhysical ActivityNeurorehabilitation

Outcome Measures

Primary Outcomes (1)

  • Steps Per Day

    Continuous activity data collection via commercially-available remote monitoring device and stored on server.

    up to 8 weeks

Secondary Outcomes (12)

  • Sensory Organization Test

    change from initiation to 2-weeks after initiation of daily wearing of TW or SW

  • Gait Velocity

    change from initiation to 2-weeks after initiation of daily wearing of TW or SW

  • Movement Ability Measure, Computer Adaptive Test Version (MAM-CAT)

    change from initiation to 2-weeks after initiation of daily wearing of TW or SW

  • Activities-Specific Balance Confidence Scale

    change from initiation to 2-weeks after initiation of daily wearing of TW or SW

  • Multiple Sclerosis Impact Scale 29

    change from initiation to 2-weeks after initiation of daily wearing of TW or SW

  • +7 more secondary outcomes

Study Arms (2)

Torso Weights then Sham Weights

EXPERIMENTAL

No weights worn for 4 weeks. Garment with torso weights worn 2-4 hours daily for 2 weeks. Then participants cross-over to wear garment with sham weights for 2-4 hours daily for 2 weeks. Participants wear the Fitbit Flex throughout.

Device: Torso WeightsDevice: Sham WeightsDevice: Fitbit Flex

Sham Weights then Torso Weights

EXPERIMENTAL

No weights worn for 4 weeks. Garment with sham weights worn 2-4 hours daily for 2 weeks. Then participants cross-over to wear garment with torso weights for 2-4 hours daily for 2 weeks. Participants wear the Fitbit Flex throughout.

Device: Torso WeightsDevice: Sham WeightsDevice: Fitbit Flex

Interventions

Following assessment of an individual's directional instability, small weights are applied to a vest-like garment to correct balance loss.

Also known as: WT
Sham Weights then Torso WeightsTorso Weights then Sham Weights

Following assessment of an individual's directional instability, small weights are applied to a vest-like garment to correct balance loss. The garment is then taken by another investigator and the actual weights are replaced with sham weights.

Also known as: SW
Sham Weights then Torso WeightsTorso Weights then Sham Weights

Potential effect on participants' physical activity to see their own step count using this wrist-worn remote monitoring device.

Also known as: remote activity monitoring device
Sham Weights then Torso WeightsTorso Weights then Sham Weights

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Self-reported a diagnosis of multiple sclerosis
  • Self-reported mild or moderate gait or balance difficulties
  • Living in the community rather than in a care facility
  • Able to walk independently for at least one minute at a time with or without an assistive device
  • No exacerbations within the past 2 months
  • Able to get to the testing area and tolerate 2-3 hours of testing for each assessment occasion
  • Willing to be nudged by a researcher when standing

You may not qualify if:

  • Unable to comprehend and follow instructions in English
  • Current diagnosis of other neurological disorders such as head injury, stroke, Parkinson disease, or other conditions that affect gait or balance (self-reported)
  • Experiencing pain that could be exacerbated by external perturbation while standing
  • History of skin reaction to adhesives

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Samuel Merritt University, Motion Analysis Research Center

Oakland, California, 94609, United States

Location

MeSH Terms

Conditions

Multiple SclerosisMotor Activity

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesBehavior

Results Point of Contact

Title
Dr. Diane Allen
Organization
San Francisco State University

Study Officials

  • Diane Allen, PhD

    San Francisco State University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 7, 2015

First Posted

April 19, 2016

Study Start

November 1, 2015

Primary Completion

May 1, 2016

Study Completion

June 1, 2016

Last Updated

November 6, 2018

Results First Posted

November 6, 2018

Record last verified: 2018-10

Locations